Essay 2-3 pages synthesis

Hi I need a paper done for synthesis for nursing by this Saturday Night 10/23/2021. Thank you so much for your help. 

topic : Non adherence to Type 2 diabetic medications 

Directions: 

Develop a substantive outline of 2- to 3-pages using the Synthesis Outline Template and incorporate each of the six critical areas.

Use information and feedback from previous submissions to complete your outline. Incorporate your references to support each area.

Include a title page, identified risks, and benefits associated with your proposed intervention.

Note: Use primary sources. Include the best and most recent evidence in your references. Older sources can be used if they are considered classic, foundational, or offer something essential; otherwise, avoid including them.

Synthesis Outline Template (MUST HAVE ALL THESE INCLUDED IN THE PAPER)

I. Introduction

a. The Problem

b. Purpose of the Paper

II. Background

III. Theoretical Framework

IV. Intervention

V. Evaluation

VI. Risks and Benefits

VII. Health Policy Implications

a. Access

b. Cost

c. Quality

VIII. Conclusion

References

pls use the the Six Critical Areas 

1. State the problem your intervention addresses. Include the macro problem and long-term goal, as well as the associated micro problem and short-term goal.
 a. Macro: increased health care cost, increased outpatient cost, increased hospitalizations, ER visits, increased complications and increased mortality and morbidity. Long term goal would be to decrease health care cost, visits to ER, hospitalizations by medication adherence to decrease diabetic complications.
  b. Micro: hyper/hypoglycemic levels, medication burden, poly pharmacy. Short term goes would be to introducing healthy eating, physical activity, and taking medications right doses at the right times. Provide follow up appointments throughout the year to keep constant communication with patient.
 2. State the purpose of the paper.
 a. The purpose of this paper is to discuss medication nonadherence and barriers to medication adherence, self-management, and the role for a provider to optimize goals for diabetic type II patients.
b. In addition, it proposes an intervention intended to improve medication adherence to assure the efforts of healthcare providers are effective and patient is well informed. .
    3. Who is the target population and the population of interest? (Are they the same?)
Target population is patients that are diagnosed with diabetes II and on medications who are not adherent and has barriers.
4. State the proposed intervention, the purpose of the intervention, and how you will measure its
effectiveness.
 a. The intervention is a have weekly educational group meeting to follow up with diabetic patients.
  b. The purpose of the intervention is to improve medication adherence and reduce the A1c, thus reduce complications of diabetes.
  c. The measurement will include regular follow up to ensure effectiveness of educational programs, monitor progression of disease and long-term implications.
 5. Identify the theoretical framework that supports the effectiveness of your intervention. (Consider how you will link your framework and your intervention.)
 a. Framework: The Self-regulatory Theory
  b. How will you link your framework and your intervention? Through education and follow ups to provide the best knowledge for the patient and make sure the patient is capable of self-care and self-management
 6. Identify the health policy implications (of the micro problem), as well as how your intervention is intended to affect each of them.
 a. Access: there is about 16.0% of adults are diabetic adults are uninsured.
 I. Implications: lack of follow up and education, lack of financial assistance, insurance

  II. Impact: due to lack of access increases the chances of medication adherence.
 b. Cost: high-cost medications, out of pocket payments,
 I. Implications: physician visits, follow up care, lack of care II. Impact: increased hospitalization, increased complication
 c. Quality: quality of life and quality of care
 I. Implications: diminished quality of life due to complications, decreased ability for the outpatient setting to provide excellent care
II. Impact: increased complications leading to morbidity and mortality, increased hospitalizations and ER visits.

Refrences: pls include these referring the paper

Macro Problem
Polonsky, W. H., & Henry, R. R. (2016, July 22). Poor medication adherence in type 2 diabetes: Recognizing the scope of the problem and its key contributors. Patient preference and adherence.

 Micro
Sapkota, S., Brien, J. A., Greenfield, J., & Aslani, P. (2015). A systematic review of interventions addressing adherence to anti-diabetic medications in patients with type 2 diabetes— impact on adherence. PloS one, 10(2), e0118296.

introduction
 Giorgino, F., Penfornis, A., Pechtner, V., Gentilella, R., & Corcos, A. (2018). Adherence to antihyperglycemic medications and glucagon-like peptide 1- receptor agonists in type 2 diabetes: clinical consequences and strategies for improvement. Patient preference and adherence, 12, 707.
 
Intervention
Vos, R. C., Eikelenboom, N. W., Klomp, M., Stellato, R. K., & Rutten, G. E. (2016). Diabetes self-management education after pre-selection of patients: design of a randomised controlled trial. Diabetology & metabolic syndrome, 8(1), 82.
 

Theoretical Framework
Bagnasco, A., Di Giacomo, P., Da Rin Della Mora, R., Catania, G., Turci, C., Rocco, G., & Sasso, L. (2014). Factors influencing self?management in patients with type 2 diabetes: a quantitative systematic review protocol. Journal of advanced nursing, 70(1), 187-200.

Johnson, M. J. (2002, July 1). The medication adherence model: A guide for assessing medication taking. Research and Theory for Nursing Practice.

Health Policy

? Access ? Cost ? Quality
 Ryan, J. G., Fedders, M., Jennings, T., Vittoria, I., & Yanes, M. (2014). Clinical outcomes and incremental costs from a medication adherence pilot intervention targeting low-income patients with diabetes at risk of cost-related medication non-adherence. Clinical therapeutics, 36(12), 1991-2002.

Kennedy-Martin, T., Boye, K. S., & Peng, X. (2017). Cost of medication adherence and persistence in type 2 diabetes mellitus: a literature review. Patient preference and adherence, 11, 1103.

Brundisini, F., Vanstone, M., Hulan, D., DeJean, D., & Giacomini, M. (2015). Type 2 diabetes patients’ and providers’ differing perspectives on medication non-adherence: a qualitative meta-synthesis. BMC health services research, 15(1), 516.